Edition:
United Kingdom

Nevro Corp (NVRO.N)

NVRO.N on New York Stock Exchange

54.33USD
17 Oct 2018
Change (% chg)

$-0.76 (-1.38%)
Prev Close
$55.09
Open
$54.98
Day's High
$54.98
Day's Low
$54.33
Volume
1,502
Avg. Vol
124,358
52-wk High
$94.32
52-wk Low
$35.55

Chart for

About

Nevro Corp. is a global medical device company. The Company focuses on providing products that improve the quality of life of patients suffering from chronic pain. The Company has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic... (more)

Overall

Beta: --
Market Cap(Mil.): $2,714.65
Shares Outstanding(Mil.): 29.44
Dividend: --
Yield (%): --

Financials

  NVRO.N Industry Sector
P/E (TTM): -- 32.37 33.73
EPS (TTM): -1.37 -- --
ROI: -10.41 14.01 14.31
ROE: -16.35 16.77 16.04

BRIEF-Nevro Reports Qtrly Loss Per Share $0.59

* REITERATES ITS EXPECTATIONS FOR WORLDWIDE REVENUE FOR 2018 TO BE IN RANGE OF $400 TO $410 MILLION

07 May 2018

Earnings vs. Estimates